Skip to main content
. 2021 Jul 20;105(8):1808–1817. doi: 10.1097/TP.0000000000003496

FIGURE 3.

FIGURE 3.

Dosing and crossmatch of patients receiving >1 dose of imlifidase. CDC, complement-dependent cytotoxicity; DD, deceased donor; LD, living donor.